ArticleBiostatistics (Oxford, England)2012
A Gaussian copula approach for the analysis of secondary phenotypes in case-control genetic association studies.
Article in Biostatistics (Oxford, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 58 citations in OpenAlex.
- A novel association test for multiple secondary phenotypes from a case-control GWAS.Genetic epidemiology · 2017Trial
- A Likelihood Approach to Proper Analysis of Secondary Outcomes in Matched Case-Control Studies.Biometrical journal. Biometrische Zeitschrift · 2026Article
- Time-coexpress: temporal trajectory modeling of dynamic gene co-expression patterns using single-cell transcriptomics data.BMC bioinformatics · 2025Article
- A novel phenotype imputation method with copula model.BMC bioinformatics · 2024Article
- Article
- Analysis of secondary phenotypes in multigroup association studies.Biometrics · 2020Article
- STEPS: an efficient prospective likelihood approach to genetic association analyses of secondary traits in extreme phenotype sequencing.Biostatistics (Oxford, England) · 2020Article
- Modeling Hybrid Traits for Comorbidity and Genetic Studies of Alcohol and Nicotine Co-Dependence.The annals of applied statistics · 2018Article
- PennDiff: detecting differential alternative splicing and transcription by RNA sequencing.Bioinformatics (Oxford, England) · 2018Article
- A multi-locus genetic association test for a dichotomous trait and its secondary phenotype.Statistical methods in medical research · 2018Article
- Weighted pseudolikelihood for SNP set analysis with multiple secondary outcomes in case-control genetic association studies.Biometrics · 2017Article
- Secondary phenotype analysis in ascertained family designs: application to the Leiden longevity study.Statistics in medicine · 2017Article
- A Robust and Powerful Set-Valued Approach to Rare Variant Association Analyses of Secondary Traits in Case-Control Sequencing Studies.Genetics · 2017Article
- Validity of using ad hoc methods to analyze secondary traits in case-control association studies.Genetic epidemiology · 2016Article
- Article
- Copula regression analysis of simultaneously recorded frontal eye field and inferotemporal spiking activity during object-based working memory.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015Article
- Integrative genomics identifies 7p11.2 as a novel locus for fever and clinical stress response in humans.Human molecular genetics · 2015Article
- More powerful genetic association testing via a new statistical framework for integrative genomics.Biometrics · 2014Article
- An alternative hypothesis testing strategy for secondary phenotype data in case-control genetic association studies.Frontiers in genetics · 2014Article
- Quantitative trait analysis in sequencing studies under trait-dependent sampling.Proceedings of the National Academy of Sciences of the United States of America · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
In many case-control genetic association studies, a set of correlated secondary phenotypes that may share common genetic factors with disease status are collected. Examination of these secondary phenotypes can yield valuable insights about the disease etiology and supplement the main studies. However, due to unequal sampling probabilities between cases and controls, standard regression analysis that assesses the effect of SNPs (single nucleotide polymorphisms) on secondary phenotypes using cases only, controls only, or combined samples of cases and controls can yield inflated type I error rates when the test SNP is associated with the disease. To solve this issue, we propose a Gaussian copula-based approach that efficiently models the dependence between disease status and secondary phenotypes. Through simulations, we show that our method yields correct type I error rates for the analysis of secondary phenotypes under a wide range of situations. To illustrate the effectiveness of our method in the analysis of real data, we applied our method to a genome-wide association study on high-density lipoprotein cholesterol (HDL-C), where "cases" are defined as individuals with extremely high HDL-C level and "controls" are defined as those with low HDL-C level. We treated 4 quantitative traits with varying degrees of correlation with HDL-C as secondary phenotypes and tested for association with SNPs in LIPG, a gene that is well known to be associated with HDL-C. We show that when the correlation between the primary and secondary phenotypes is >0.2, the P values from case-control combined unadjusted analysis are much more significant than methods that aim to correct for ascertainment bias. Our results suggest that to avoid false-positive associations, it is important to appropriately model secondary phenotypes in case-control genetic association studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.